Skip to main content

Table 2 Serum visfatin levels [shown as medians and (Q1–Q3)] according to the vascular territory affected

From: Association between serum visfatin levels and atherosclerotic plaque in patients with type 2 diabetes

Parameters

Visfatin (ng/mL)

No plaque (n = 41)

0.45 (0.23–0.76)

Carotid plaques (n = 20)

2.37 (0.74–6.27)a,b,c

Femoral plaques (n = 20)

0.49 (0.38–0.66)

Both carotid and femoral plaques (n = 16)

0.68 (0.55–1.25)a,b

  1. aP < 0.01 versus No plaque group
  2. bP < 0.05 versus femoral plaques group
  3. cP < 0.05 versus both carotid and femoral plaques group (Mann–Whitney U test)
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us